Table 5.
Baseline | 29–32 weeks | Change from Baseline | |
---|---|---|---|
CRP | 0.76* | 0.19 | 0.14 |
PGE2 | 0.62 | 0.44 | 0.91 |
MMP-9 | 0.72 | 0.68 | 0.46 |
Fibrinogen | 0.30 | 0.08 | 0.22 |
Endotoxin | 0.87 | 0.17 | 0.45 |
P value from multiple linear regression with birthweight as the dependent variable and the serum marker (log10), age, sex and BMI as independent variables. Treatment group also included as an independent variable in the analysis of the 29–32 week data (columns 2 and 3). P values in column 1 correspond to data shown in Figure 2.